Nutrición Hospitalaria 00626 / http://dx.doi.org/10.20960/nh.626
Resumen| PDF (ENGLISH)

Trabajo Original

Lactobacillus rhamnosusgg reduces hepatic fibrosis in a model of chronic liver disease in rats


Thais Ortiz Hammes, Renata Leke, Thayssa Dalla Costa Escobar, Laisa Beduschi Fracasso, Fabiola Schons Meyer, Michael Éverton Andrades, Themis Reverbel Da Silveira

Logo Descargas   Número de descargas: 2290      Logo Visitas   Número de visitas: 8076      Citas   Citas: 14

Compártelo:


Background:The intestinal dysbiosis is common in chronic liver disease and can induce to inflammatory responses and mediate the collagen deposition in the liver. Aim:To evaluate the probiotic Lactobacillus rhamnosus GG (LGG) for the treatment of liver fibrosis in a model of chronic cholestatic liver disease in rats. Methods: Male adult Wistar rats (n = 29) were submitted to common bile duct ligation (BDL groups) or manipulation of common bile duct without ligation (Ctrl groups).Two weeks after surgery, each group was randomly divided to receive 1 ml of PBS (Ctrl and BDL) or PBS containing 2.5 x 107 CFU of LGG (Ctrl-P and BDL-P) through gavages for 14 days. Euthanasia occurred 33 days after surgery when samples of blood and liver tissue were collected.Results: The hepatic gene expression of Tlr4, Tnfα, IL-6, Tgfβ, and metalloproteinase-2 and -9 were higher in the BDL groups in comparison to Ctrl. The ductular reaction evaluated by immunocontent of cytokeratin-7 (CK7) and the content of collagen were increased in BDL groups. Also, there was an imbalance in the antioxidant defenses (superoxide dismutase and catalase) and an increase in the oxidative stress marker sulfhydryl in BDL groups. The treatment with LGG significantly reduced gene expression of IL-6, collagen deposition, and ductular reaction in hepatic tissue of animals from BDL-P groups.Conclusion: The treatment with the probiotic LGG was able to reduce liver fibrosis, ductular reaction, and hepatic gene expression of IL-6 in a model of cholestatic liver disease in rats.

Palabras Clave: Probiotics. Liver fibrosis. Bile duct-ligated rats. Lactobacillus rhamnosus.



Rackayová, Veronika, Flatt, Emmanuelle, Braissant, Olivier, Grosse, Jocelyn, Capobianco, Daniela, Mastromarino, Paola, McMillin, Matthew, DeMorrow, Sharon, McLin, Valérie A., Cudalbu, Cristina (2021) Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease. Scientific Reports
Liu, Yunhuan, Chen, Kefei, Li, Fengyuan, Gu, Zelin, Liu, Qi, He, Liqing, Shao, Tuo, Song, Qing, Zhu, Fenxia, Zhang, Lihua, Jiang, Mengwei, Zhou, Yun, Barve, Shirish, Zhang, Xiang, McClain, Craig J., Feng, Wenke (2020) Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice. Hepatology
Flatt, Emmanuelle, McLin, Valérie A., Braissant, Olivier, Pierzchala, Katarzyna, Mastromarino, Paola, Mitrea, Stefanita-Octavian, Sessa, Dario, Gruetter, Rolf, Cudalbu, Cristina (2021) Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE. Scientific Reports
Ren, Li, Song, Qing, Liu, Yunhuan, Zhang, Lihua, Hao, Zhiming, Feng, Wenke (2019) Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury. Biochemical and Biophysical Research Communications
Kwon, Jeong Eun, Hong, Woojae, Jeon, Hyelin, Kim, Cha Soon, Kim, Hyunggun, Kang, Se Chan (2024) Suppression of P2X4 and P2X7 by Lactobacillus rhamnosus vitaP1: effects on hangover symptoms. AMB Express
Shen, Kuo, Han, Fu, Cheng, Jing, Han, Shichao, Wang, Xiaolei, Xin, Keke, Hu, Dahai, Wu, Gaofeng (2022) The Mechanism of <i>Lactobacillus Delbruckii</i>&nbsp;Inhibiting Hypertrophic Scar Fibrosis Based on Proteome and Transcriptome Analysis. SSRN Electronic Journal
Wen, Ya, Wu, Qunfu, Zhang, Longlong, He, Jiangbo, Chen, Yonghong, Yang, Xiaoyu, Zhang, Keqin, Niu, Xuemei, Li, Shenghong (2022) Association of Intrauterine Microbes with Endometrial Factors in Intrauterine Adhesion Formation and after Medicine Treatment. Pathogens
Wang, Li, Cui, Huantian, Li, Yuting, Cao, Min, Man, Shanshan, Guo, Liying, Miao, Jing, Jia, Jianwei, Bian, Yuhong, Zhang, Zhaiyi, Kim, Bonglee (2020) Kang-Xian Pills Inhibit Inflammatory Response and Decrease Gut Permeability to Treat Carbon Tetrachloride-Induced Chronic Hepatic Injury through Modulating Gut Microbiota. Evidence-Based Complementary and Alternative Medicine
Wu, Chia-Ta, Lin, Fei-Hung, Lee, Yu-Tzu, Ku, Min-Sho, Lue, Ko-Haung (2019) Effect of Lactobacillus rhamnosus GG immunopathologic changes in chronic mouse asthma model. Journal of Microbiology, Immunology and Infection
Zhu, Tao, Mao, Jiangdi, Zhong, Yifan, Huang, Congxiang, Deng, Zhaoxi, Cui, Yanjun, Liu, Jianxin, Wang, Haifeng (2021) L. reuteri ZJ617 inhibits inflammatory and autophagy signaling pathways in gut-liver axis in piglet induced by lipopolysaccharide. Journal of Animal Science and Biotechnology
Kessoku, Takaomi, Kobayashi, Takashi, Imajo, Kento, Tanaka, Kosuke, Yamamoto, Atsushi, Takahashi, Kota, Kasai, Yuki, Ozaki, Anna, Iwaki, Michihiro, Nogami, Asako, Honda, Yasushi, Ogawa, Yuji, Kato, Shingo, Higurashi, Takuma, Hosono, Kunihiro, Yoneda, Masato, Okamoto, Takayuki, Usuda, Haruki, Wada, Koichiro, Kobayashi, Noritoshi, Saito, Satoru, Nakajima, Atsushi (2021) Endotoxins and Non-Alcoholic Fatty Liver Disease. Frontiers in Endocrinology
Abaturov, A.E., Babуch, V.L. (2024) Drug regulation of microRNA. CHILD`S HEALTH
Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015 Feb 13.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=25681399
Forbes SJ, Parola M. Liver fibrogenic cells. Best Practice & Research Clinical Gastroenterology. 2011 Apr;25(2):207-17.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21497739
Dranoff JA, Wells RG. Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology. 2010 Apr;51(4):1438-44.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20209607
Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008 May;134(6):1655-69.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18471545
Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol. 2012 Feb 1;590(Pt 3):447-58.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22124143
Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Natue Medicine. 2007 Nov;13(11):1324-32.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17952090
Szabo G, Bala S, Petrasek J, Gattu A. Gut-liver axis and sensing microbes. Digestive Disease. 2010;28(6):737-44.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21525758
Sommacal HM, Bersch VP, Vitola SP, Osvaldt AB. Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial. Nutr Cancer. 2015 Apr;67(3):457-62.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=25803626
Pithva S, Shekh S, Dave J, Vyas BR. Probiotic attributes of autochthonous Lactobacillus rhamnosus strains of human origin. Appl Biochem Biotechnol. 2014 May;173(1):259-77.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=24682879
Zhao H, Zhao C, Dong Y, Zhang M, Wang Y, Li F, et al. Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease. Toxicol Lett. 2015 May 5;234(3):194-200.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=25746479
Hibberd PL, Kleimola L, Fiorino AM, Botelho C, Haverkamp M, Andreyeva I, et al. No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses. PLoS One. 2014;9(12):e113456.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=25438151
Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol (Fayetteville, NY. 2009 Mar;43(2):163-72.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19251117
Vajro P, Mandato C, Licenziati MR, Franzese A, Vitale DF, Lenta S, et al. Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. Journal of pediatric gastroenterology and nutrition. 2011 Jun;52(6):740-3.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21505361
Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Alimentary Pharmacology & Therapeutics. 2007 Apr 15;25(8):871-81.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17402990
Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, Puri P, Sterling RK, et al. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther. 2014 May;39(10):1113-25.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=24628464
Leke R, Oliveira DL, Forgiarini LF, Escobar TD, Hammes TO, Meyer FS, et al. Impairment of short term memory in rats with hepatic encephalopathy due to bile duct ligation. Metab Brain Dis. 2013 Jun;28(2):187-92.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=23111918
Soszynski M, Bartosz G. Decrease in accessible thiols as an index of oxidative damage to membrane proteins. Free Radic Biol Med. 1997;23(3):463-9.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9214583
Li Y, Schellhorn HE. Rapid kinetic microassay for catalase activity. J Biomol Tech. 2007 Sep;18(4):185-7.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17916790
Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972 May 25;247(10):3170-5.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=4623845
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248-54.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=942051
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402-8.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11846609
Santos JL, Kieling CO, Meurer L, Vieira S, Ferreira CT, Lorentz A, et al. The extent of biliary proliferation in liver biopsies from patients with biliary atresia at portoenterostomy is associated with the postoperative prognosis. J Pediatr Surg. 2009 Apr;44(4):695-701.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19361628
Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577-80.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6166661
Vercelino R, Crespo I, de Souza GF, Cuevas MJ, de Oliveira MG, Marroni NP, et al. S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats. J Mol Med (Berl). 2010 Apr;88(4):401-11.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20062961
Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F, et al. Characterization of time-related changes after experimental bile duct ligation. Br J Surg. 2008 May;95(5):646-56.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18196571
Zhou YK, Qin HL, Zhang M, Shen TY, Chen HQ, Ma YL, et al. Effects of Lactobacillus plantarum on gut barrier function in experimental obstructive jaundice. World J Gastroenterol. 2012 Aug 14;18(30):3977-91.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22912548
Ramadori G, Saile B. Portal tract fibrogenesis in the liver. Lab Invest. 2004 Feb;84(2):153-9.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14688800
Wells RG, Kruglov E, Dranoff JA. Autocrine release of TGF-beta by portal fibroblasts regulates cell growth. FEBS Lett. 2004 Feb 13;559(1-3):107-10.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14960316
Hammes TO, Pedroso GL, Hartmann CR, Escobar TD, Fracasso LB, da Rosa DP, et al. The effect of taurine on hepatic steatosis induced by thioacetamide in zebrafish (Danio rerio). Dig Dis Sci. 2012 Mar;57(3):675-82.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21997755
D'Argenio G, Cariello R, Tuccillo C, Mazzone G, Federico A, Funaro A, et al. Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage? Liver Int. 2013 May;33(5):687-97.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=23448378
Liu Y, Liu Q, Ye G, Khan A, Liu J, Gan F, et al. Protective Effects of Selenium-Enriched Probiotics on Carbon Tetrachloride-Induced Liver Fibrosis in Rats. J Agric Food Chem. 2014 Dec 31.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=25513970
Rashid SK, Khodja NI, Auger C, Alhosin M, Boehm N, Oswald-Mammosser M, et al. Probiotics (VSL#3) prevent endothelial dysfunction in rats with portal hypertension: role of the angiotensin system. PLoS One. 2014;9(5):e97458.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=24832090
Gehring S, Dickson EM, San Martin ME, van Rooijen N, Papa EF, Harty MW, et al. Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology. 2006 Mar;130(3):810-22.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16530521
Nakamoto N, Kanai T. Role of toll-like receptors in immune activation and tolerance in the liver. Front Immunol. 2014;5:221.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=24904576
Aoyama T, Paik YH, Seki E. Toll-like receptor signaling and liver fibrosis. Gastroenterol Res Pract. 2010;2010.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20706677
Hammerich L, Tacke F. Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clin Exp Gastroenterol. 2014;7:297-306.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=25214799
Wang H, Lafdil F, Kong X, Gao B. Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci. 2011;7(5):536-50.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21552420
Nieto N. Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells. Hepatology. 2006 Dec;44(6):1487-501.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17133487
Bateman AC, Hubscher SG. Cytokeratin expression as an aid to diagnosis in medical liver biopsies. Histopathology. 2010 Mar;56(4):415-25.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20459548

Artículos más populares

Revisión: Ayuno intermitente: efectos en diversos escenarios clínicos

Introducción: los esquemas de ayuno intermitente (...

Publicado: 2023-05-24

Trabajo Original: Body mass index and risk of inflammatory breast disease: a Mendelian randomization study

Introduction: in previous studies, obesity was ide...

Publicado: 2023-04-22

Revisión: Relación entre la dieta, aspectos nutricionales y la calidad del sueño en población pediátrica

.La relación entre la dieta y el sueño ha sido esc...

Publicado: 2023-06-08

Una cookie o galleta informática es un pequeño archivo de información que se guarda en su navegador cada vez que visita nuestra página web. La utilidad de las cookies es guardar el historial de su actividad en nuestra página web, de manera que, cuando la visite nuevamente, ésta pueda identificarle y configurar el contenido de la misma en base a sus hábitos de navegación, identidad y preferencias. Las cookies pueden ser aceptadas, rechazadas, bloqueadas y borradas, según desee. Ello podrá hacerlo mediante las opciones disponibles en la presente ventana o a través de la configuración de su navegador, según el caso. En caso de que rechace las cookies no podremos asegurarle el correcto funcionamiento de las distintas funcionalidades de nuestra página web. Más información en el apartado “POLÍTICA DE COOKIES” de nuestra página web.